Skye Bioscience, Inc.

SKYE chart

Skye Bioscience, Inc. news

• Skye Bioscience Inc (SKYE) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Fibrex ...

  Yahoo Finance · Aug 17, 1:32 PM EDT

• Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings

  Yahoo Finance · Aug 14, 9:33 AM EDT

• The weight-loss drugs boom is creating both winners and wipeouts: One Big Investment Idea

  Yahoo Finance · Jul 17, 6:39 AM EDT

• Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1

  Yahoo Finance · May 20, 7:00 AM EDT

• UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update

  Yahoo Finance · May 12, 1:33 PM EDT

• Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update

  Yahoo Finance · May 11, 4:01 PM EDT

• Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit

  Yahoo Finance · Apr 7, 7:00 AM EDT

• Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development

  Yahoo Finance · Apr 2, 7:00 AM EDT

• Halozyme Therapeutics Touts $1.8B Revenue Outlook, ENHANZE Royalties and New Hypercon Deals at Conference

  marketbeat.com · Mar 18, 1:06 AM EDT

• Skye Bioscience Inc (SKYE) Q4 2025 Earnings Call Highlights: Pioneering Advances in Obesity ...

  Yahoo Finance · Mar 11, 9:04 PM EDT

• Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

  Yahoo Finance · Mar 10, 4:01 PM EDT

• Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026

  Yahoo Finance · Mar 5, 7:00 AM EST

Skye Bioscience, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-09-11
• 8-K8-K2026-08-24
• 8-K/A8-K/A2026-08-20
• 8-K8-K2026-08-19
• 10-Q10-Q2026-08-14
• 8-K8-K2026-08-14
• 8-K8-K2026-06-23
• 8-K8-K2026-05-29
• 8-K8-K2026-05-15
• 10-Q10-Q2026-05-11
• DEF 14ADEF 14A2026-04-16
• 8-K/A8-K/A2026-04-06

About Skye Bioscience, Inc.

Ticker

SKYE (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

San Diego, CA

Incorporated in

NV

Fiscal year end

December 31

SEC CIK

1516551

Former names

Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC.

Frequently asked questions